| Dr David Krieger, MD | |
|
21097 Ne 27th Ct, Suite 320, Aventura, FL 33180-1204 | |
| (305) 933-9440 | |
| (305) 933-9424 |
| Full Name | Dr David Krieger |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 16 Years |
| Location | 21097 Ne 27th Ct, Aventura, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508033101 | NPI | - | NPPES |
| 1508033101 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | ME122835 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aventura Hospital And Medical Center | Aventura, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Broward Neurosurgeons Llc | 8123096690 | 21 |
News Archive
Engineers at the University of Sheffield have developed a method of assisting nerves damaged by traumatic accidents to repair naturally, which could improve the chances of restoring sensation and movement in injured limbs.
Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.
The majority of cancer drugs recently approved by the US Food and Drug Administration on the basis of a surrogate endpoint either have an unknown effect on overall survival or have failed to show a survival benefit, say the authors of a research letter.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).
As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to allow viral entry.
› Verified 4 days ago
| Entity Name | Broward Neurosurgeons Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366499618 PECOS PAC ID: 8123096690 Enrollment ID: O20040922000609 |
News Archive
Engineers at the University of Sheffield have developed a method of assisting nerves damaged by traumatic accidents to repair naturally, which could improve the chances of restoring sensation and movement in injured limbs.
Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.
The majority of cancer drugs recently approved by the US Food and Drug Administration on the basis of a surrogate endpoint either have an unknown effect on overall survival or have failed to show a survival benefit, say the authors of a research letter.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).
As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to allow viral entry.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Krieger, MD 21097 Ne 27th Ct, Suite 320, Aventura, FL 33180-1204 Ph: (305) 933-9440 | Dr David Krieger, MD 21097 Ne 27th Ct, Suite 320, Aventura, FL 33180-1204 Ph: (305) 933-9440 |
News Archive
Engineers at the University of Sheffield have developed a method of assisting nerves damaged by traumatic accidents to repair naturally, which could improve the chances of restoring sensation and movement in injured limbs.
Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.
The majority of cancer drugs recently approved by the US Food and Drug Administration on the basis of a surrogate endpoint either have an unknown effect on overall survival or have failed to show a survival benefit, say the authors of a research letter.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).
As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to allow viral entry.
› Verified 4 days ago
Dr. Andrew Michael Lozen, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 21097 Ne 27th Ct Ste 320, Aventura, FL 33180 Phone: 305-937-3022 Fax: 305-937-3023 | |
Ms. Linda L. Sternau, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2801 Ne 213th St Ste 809, Aventura, FL 33180 Phone: 305-697-2848 Fax: 305-697-2877 |